Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Understanding-COVID-19_pagePreview
Managing Patient Enrollment in Acromegaly Rare Disease Studies

In rare disease, every patient matters and it is important for CRO and sponsor medical staff to effectively monitor and...


(2 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Challenges Working with Terminally-Ill Patients in an International Rare Disease Study

Pharm-Olam is a clinical research organization (CRO) that has vast experience in rare diseases. To date, we have completed...


(3 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Natural History - Case Study: Ultra Rare Disease in Subjects Aged 3 Years and Younger

Pharm-Olam is a clinical research organization (CRO) with global reach and deep expertise in rare disease research. Our...


(3 minute read)

Tags: Rare & Orphan Disease

The Future of Rare Disease Research

March was Rare Disease Month at Pharm-Olam. We started off by reviewing an article that was published in Nature (read it here...


(2 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

The Use of Drug Repurposing in Rare Disease Research

Rare Disease Day may have been on 29 February, but at Pharm-Olam, we think it desires an entire month. Since the beginning of...


(3 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

The Use of Gene Therapies in Rare Disease Research

At Pharm-Olam, March is Rare Disease Month. Over the past three weeks, we have been exploring the subject in greater detail....


(3 minute read)

Tags: Rare & Orphan Disease

The Use of Oligonucleotide Therapies in Rare Disease Research

Rare disease research is such a complicated area because it involves every therapeutic area individually and sometimes in...


(3 minute read)

Tags: Rare & Orphan Disease

The Use of Protein Replacement Therapies in Rare Disease Research

Rare disease research can take many forms, and each drug development platform offers specific advantages researchers can...


(3 minute read)

Tags: Rare & Orphan Disease

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.

GDPR_Checklist-cover